Medicina
Departamento
FRANCISCO
VANACLOCHA SEBASTIÁN
Investigador en el periodo 2009-2016
Publicaciones en las que colabora con FRANCISCO VANACLOCHA SEBASTIÁN (90)
2019
-
Erythema migrans… again
Piel, Vol. 34, Núm. 2, pp. 123-125
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2017
-
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 6, pp. 1021-1028
-
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
Journal of Investigative Dermatology, Vol. 137, Núm. 2, pp. 313-321
-
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry
Actas dermo-sifiliograficas, Vol. 108, Núm. 1, pp. 52-58
-
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 1, pp. 52-58
-
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
British Journal of Dermatology, Vol. 176, Núm. 3, pp. 643-649
2016
-
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
Journal of Dermatological Treatment, Vol. 27, Núm. 3, pp. 203-209
-
Failure of photodynamic therapy (PDT) in 3 patients with folliculitis decalvans
Journal of the American Academy of Dermatology
-
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis
Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602
-
Initial Assessment of Patients With Contact Eczema
Actas Dermo-Sifiliograficas, Vol. 107, Núm. 9, pp. 791-793
-
Lesiones eccematosas y cuadro ictiosiforme adquirido como forma de presentación de un linfoma anaplásico de células grandes CD30+
Semergen: revista española de medicina de familia, Núm. 3, pp. 208-210
-
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis
Journal of the European Academy of Dermatology and Venereology, Vol. 30, Núm. 11, pp. 1942-1950
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
-
¿La psoriasis produce alopecia irreversible?
Actas Dermo-Sifiliograficas, Vol. 107, Núm. 6, pp. 527-530
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis
Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325
-
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 8, pp. 638-643
-
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
Actas dermo-sifiliograficas, Vol. 106, Núm. 8, pp. 638-643
-
Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: Baseline characteristics of patients in the aquiles study
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 1, pp. 35-43